| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.057 | 0.2 |